Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Wnt/beta-catenin pathway blocker C644-0303 inhibits colorectal cancer growth

Dec. 3, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical Group presents SOS1 inhibitors

Dec. 2, 2021

Suzhou Zelgen Biosciences synthesizes new GTPase KRAS mutant inhibitors

Dec. 2, 2021

FBXO22 sensitizes tumor cells to DNA damage by PD-L1 degrading

Dec. 2, 2021

Jemincare licenses JMKX-1899 ex-China rights to Huyabio

Dec. 1, 2021

Orion identifies new CYP11A1 inhibitors

Dec. 1, 2021

CSPC Zhongqi Pharmaceutical Technology divulges tyrosine kinase receptor inhibitors

Dec. 1, 2021

Scorpion Therapeutics unveils lead programs in cancer

Nov. 30, 2021

PNV-2 reduces metastases in animal model of triple-negative breast cancer

Nov. 30, 2021

Txinno Bioscience presents new ENPP1 inhibitors

Nov. 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.